Literature DB >> 25196187

In vitro and in vivo evaluations of three-dimensional hydroxyapatite/silk fibroin nanocomposite scaffolds.

Mazaher Gholipourmalekabadi1, Masoud Mozafari2, Mahdieh Gholipourmalekabadi3, Maryam Nazm Bojnordi3, Mohamad B Hashemi-Soteh4, Maryam Salimi5, Nourollah Rezaei3, Marzieh Sameni1, Ali Samadikuchaksaraei6,7,8, Hatef Ghasemi Hamidabadi3.   

Abstract

In this study, three-dimensional hydroxyapatite/silk fibroin (HAp/SF) nanocomposite scaffolds were successfully prepared through layer solvent casting combined with the freeze-drying technique for tissue engineering applications. Various SF aqueous concentrations, ranging from 2.5% to 10%, were used to control the physicochemical properties of the prepared scaffolds. Biologic responses of the rat bone marrow stromal cells (rBMSCs) to the HAp/SF scaffolds were examined by culturing the cells within them. In addition, biodegradation and biocompatibility of the scaffolds were evaluated in vitro and in vivo, respectively. Among the prepared scaffolds, HAp/SF-2.5% was the most brittle sample and showed porous structure with lowest mechanical properties. The average pore diameters were 350 ± 67 and 112 ± 89 µm and decreased with the increase in the SF concentration from 5% to 10%, respectively. The pores formed in the scaffolds, made up of the 5% SF, were more uniform and regular than those of the scaffolds made up of 5% and 10% SF. The HAp/SF scaffolds did not change the rBMSCs viability and were not cytotoxic compared with the control sample. The scanning electron microscopy micrographs showed that the cells migrated into the pores and well attached to the scaffolds and their cytoplasm was extended in all directions, indicating a promising cell adhesion, high biocompatibility, and no cytotoxicity of the HAp/SF-5% nanocomposite scaffolds. Subcutaneous implantation of the HAp/SF-5% scaffolds in rat models suggested an excellent biocompatibility. All data obtained from this study suggest the potential use of the HAp/SF-5% for hard tissue engineering.
© 2014 International Union of Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  hydroxyapatite; scaffold; silk fibroin; tissue engineering

Mesh:

Substances:

Year:  2015        PMID: 25196187     DOI: 10.1002/bab.1285

Source DB:  PubMed          Journal:  Biotechnol Appl Biochem        ISSN: 0885-4513            Impact factor:   2.431


  5 in total

1.  Development and characterization of poultry collagen-based hybrid hydrogels for bone regeneration.

Authors:  Francisco Fábio Pereira de Souza; Jesús Alberto Pérez-Guerrero; Maria Janaína Paula Gomes; Fábio Lima Cavalcante; Men de Sá Moreira de Souza Filho; Igor Iuco Castro-Silva
Journal:  Acta Cir Bras       Date:  2022-05-13       Impact factor: 1.564

2.  Decellularized human amniotic membrane: how viable is it as a delivery system for human adipose tissue-derived stromal cells?

Authors:  M Gholipourmalekabadi; M Sameni; Dina Radenkovic; M Mozafari; M Mossahebi-Mohammadi; A Seifalian
Journal:  Cell Prolif       Date:  2016-02-03       Impact factor: 6.831

3.  Repair of Critical-Sized Rat Calvarial Defects With Three-Dimensional Hydroxyapatite-Gelatin Scaffolds and Bone Marrow Stromal Stem Cells.

Authors:  Hatef Ghasemi Hamidabadi; Majid Malekzadeh Shafaroudi; Morteza Seifi; Maryam Nazm Bojnordi; Masume Behruzi; Mazaher Gholipourmalekabadi; Ali Malekzadeh Shafaroudi; Nourollah Rezaei
Journal:  Med Arch       Date:  2018-04

4.  Preparation of controlled degradation of insulin-like growth factor 1/spider silk protein nanofibrous membrane and its effect on endothelial progenitor cell viability.

Authors:  Lifang Chen; Yulang Huang; Rongfeng Yang; Jian Xiao; Jiajia Gao; Debao Zhang; Duanwen Cao; Xiao Ke
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

Review 5.  Silk fibroin/hydroxyapatite scaffold: a highly compatible material for bone regeneration.

Authors:  Muhammad Saleem; Sidra Rasheed; Chen Yougen
Journal:  Sci Technol Adv Mater       Date:  2020-04-30       Impact factor: 8.090

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.